Mohd Hanif Zulfakar
Overview
Explore the profile of Mohd Hanif Zulfakar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
236
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zulfakar M, Pubadi H, Ibrahim S, Hairul N
J Oleo Sci
. 2024 Mar;
73(3):293-310.
PMID: 38432994
Medium-chain triacylglycerol (MCT) is a type of triacylglycerol that has six or seven to twelve carbon chains. It consists of three molecules of fatty acids attached to one molecule of...
2.
Shamsuddin N, Zulfakar M
Curr Drug Deliv
. 2022 Mar;
20(2):127-143.
PMID: 35331113
Natural products contain bioactive compounds that are produced naturally via synthetic or semisynthetic processes. These bioactive compounds play significant biological roles, especially for growth as well as in defense mechanisms...
3.
Zainuddin N, Ahmad I, Zulfakar M, Kargarzadeh H, Ramli S
Carbohydr Polym
. 2020 Dec;
254:117401.
PMID: 33357890
Low bioavailability and poor water solubility have limited the utilization of curcumin in conventional dosing methods. As an alternative, microemulsions as drug carrier can improve curcumin delivery. A cetyltrimethylammonium bromide-nanocrystalline...
4.
Alcantara K, Zulfakar M, Castillo A
Int J Pharm
. 2019 Sep;
571:118705.
PMID: 31536765
Mupirocin is a promising broad-spectrum antibiotic that is effective in treating MRSA infections. However, due to its rapid elimination and hydrolysis following injection and high protein binding, current therapeutic use...
5.
Tou K, Rehman K, Ishak W, Zulfakar M
Drug Dev Ind Pharm
. 2019 Jun;
45(9):1451-1458.
PMID: 31216907
The aim of this study was to develop a coenzyme Q10 nanoemulsion cream, characterize and to determine the influence of omega fatty acids on the delivery of coenzyme Q10 across...
6.
Amran M, Zulfakar M, Danik M, Abdullah M, Shamsuddin A
Daru
. 2019 Apr;
27(1):191-201.
PMID: 31020546
Purpose: Intravenous lipid emulsion (IVLE) was first used to prevent essential fatty acids deficiency. IVLE with α-tocopherol was reported to provide protection against parenteral nutrition-associated liver disease. This study aims...
7.
Ishak W, Katas H, Yuen N, Abdullah M, Zulfakar M
Drug Deliv Transl Res
. 2018 Apr;
9(2):418-433.
PMID: 29667150
Wound healing is a physiological event that generates reconstitution and restoration of granulation tissue that ends with scar formation. As omega fatty acids are part of membrane phospholipids and participate...
8.
Zulfakar M, Chan L, Rehman K, Wai L, Heard C
AAPS PharmSciTech
. 2017 Nov;
19(3):1116-1123.
PMID: 29181705
Coenzyme Q10 (CoQ10) is a vitamin-like oil-soluble molecule that has anti-oxidant and anti-ageing effects. To determine the most optimal CoQ10 delivery vehicle, CoQ10 was solubilised in both water and fish...
9.
Siddique M, Katas H, Jamil A, Amin M, Ng S, Zulfakar M, et al.
Drug Deliv Transl Res
. 2017 Nov;
9(2):469-481.
PMID: 29159691
Hydrocortisone (HC), topical glucocorticoid along with hydroxytyrosol (HT), and anti-microbial- and anti-oxidant-loaded chitosan nanoparticles (CSNPs) were prepared in large scale and analyzed for their adverse effects on healthy human skin...
10.
Rehman K, Zulfakar M
Pharm Res
. 2016 Sep;
34(1):36-48.
PMID: 27620176
Purpose: To characterize bigel system as a topical drug delivery vehicle and to establish the immunomodulatory role of imiquimod-fish oil combination against skin cancer and inflammation resulting from chemical carcinogenesis....